Significant decline in anticancer immune capacity during puberty in the Tasmanian devil

Sci Rep. 2017 Mar 16:7:44716. doi: 10.1038/srep44716.

Abstract

Tasmanian devils (Sarcophilus harrisii) are at risk of extinction in the wild due to Devil Facial Tumour Disease (DFTD), a rare contagious cancer. The prevalence of DFTD differs by age class: higher disease prevalence is seen in adults (2-3 years) versus younger devils (<2 years). Here we propose that immunological changes during puberty may play a role in susceptibility to DFTD. We show that the second year of life is a key developmental period for Tasmanian devils, during which they undergo puberty and pronounced changes in the immune system. Puberty coincides with a significant decrease in lymphocyte abundance resulting in a much higher neutrophil:lymphocyte ratio in adults than subadults. Quantitative PCR analysis of gene expression of transcription factors T-bet and GATA-3 and cytokines interferon gamma (IFN-γ) and interleukin 4 (IL-4) revealed a drastic increase in GATA-3 and IL-4 expression during puberty. These changes led to a significantly lower IFN-γ:IL-4 ratio in 2-year-olds than <1 year olds (on average 1.3-fold difference in males and 4.0-fold in females), which reflects a major shift of the immune system towards Th2 responses. These results all indicate that adult devils are expected to have a lower anticancer immune capacity than subadults, which may explain the observed pattern of disease prevalence of DFTD in the wild.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Body Weight
  • Female
  • Gene Expression Regulation
  • Interferon-gamma / metabolism
  • Interleukin-4 / metabolism
  • Lymphocyte Count
  • Lymphocytes / metabolism
  • Male
  • Marsupialia / immunology*
  • Neoplasms / blood
  • Neoplasms / immunology*
  • Neoplasms / pathology
  • Neutrophils / metabolism
  • Progesterone / blood
  • Sexual Maturation*
  • Th1 Cells / metabolism
  • Th2 Cells / metabolism

Substances

  • Interleukin-4
  • Progesterone
  • Interferon-gamma